Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 29.32

+4.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (4971)	3/21/1999 6:18:00 PM
From: JanyBlueEyes	Read Replies (1) of 5736

Cacaito There are numerous studies done with phototherapy and the bleaching effect it can have on the skin ncbi.nlm.nih.gov ncbi.nlm.nih.gov The "Elmhurst study" by SpectRx was from a long time ago and it was to collect data that they used for the FDA approval that was just announced (NOT while under phototherapy). I am of the opinion that since Chromatics is already out there selling their device (which does work if the infant undergoes phototherapy treatment), and since they had such a tremendous response at all the pediatric conventions all over the world, they will prevail in the area of bilirubin monitoring. By the time (IF) SpectRx receives approval for their device for phototherapy, Chromatics' device will be the standard used in a majority of hospitals.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next